STOCKHOLM, April 2, 2025 /PRNewswire/ — The hygiene and health company Essity has been awarded a place on the global non-profit environmental organization CDP’s “A List” for its leadership in corporate transparency and performance on climate. Over 22,000 companies from 130 countries,…
Tag: PR Newswire
Denosumab marca la sexta aprobación de biosimilar de Accord en Europa. El CHMP ha emitido una opinión positiva para Denosumab, que se comercializará como Osvyrti® y Jubereq®. Osvyrti® es el segundo biosimilar de Accord para la osteoporosis, tras Sondelbay®. La aprobación del CHMP allana…
Le denosumab est le sixième biosimilaire approuvé par Accord en Europe. Le CHMP a émis un avis positif sur le Denosumab, qui sera commercialisé sous les noms Osvyrti® et Jubereq®. Osvyrti® est le deuxième biosimilaire d’Accord pour l’ostéoporose, après Sondelbay®. L’approbation du CHMP…
Orders on DoorDash’s Marketplace will be delivered by Domino’s drivers Partnership Highlights: Domino’s Joins DoorDash Marketplace: Nationwide U.S. launch beginning in May 2025, expanding to Canada later in 2025 Seamless Integration with Self-Delivery: Domino’s drivers fulfill orders…
COSTA MESA, Calif., April 2, 2025 /PRNewswire/ — The Empower Campaign, an initiative focused on empowering people to become the best versions of themselves, is celebrating a major milestone—surpassing $1 million in total donations over the past three years at the RX3 Charity Flag…
Providers in the United States may now order the FDA-cleared HPV self-collection solution for their patients to use in their offices or other healthcare settings, with goal to reduce barriers to screening by enabling discreet self-collection Quest also plans to make self-collection option…
An evolution in hiring is overdue NEW YORK, April 2, 2025 /PRNewswire/ — Ropes, the AI-driven platform transforming how engineering talent is evaluated, announced today it has raised $3.1M in seed funding. The seed round, led by GSV Ventures with participation from Box Group, will…
Denosumab ist die sechste Biosimilar-Zulassung von Accord in Europa. Der CHMP hat eine positive Stellungnahme für Denosumab abgegeben, das als Osvyrti® und Jubereq® vermarktet werden soll. Osvyrti® ist nach Sondelbay® das zweite Osteoporose-Biosimilar von Accord. Die Empfehlung des CHMP…
The company was recognized as a top mid-sized company in the Madison area by the Wisconsin State Journal MADISON, Wis., April 2, 2025 /PRNewswire/ — Singlewire Software, the leader in solutions that help keep people safe and informed, celebrates its fifth consecutive year of being…
PITTSBURGH, April 2, 2025 /PRNewswire/ — CNX Resources Corp. (NYSE: CNX) will announce its financial results for Q1 2025 at 6:45 a.m. Eastern Time on Thursday, April 24. At that time, CNX will issue a brief press release containing links to its prepared remarks for the quarter,…